Tigis

102665299 m normal none

AVN 2026

Obsah

Editorial .................................................................................................... 33

Obsah .......................................................................................................... 35

Přehledné články

Vitamin D a VDR aktivátory – novinky v prevenci
a léčbě sekundární hyperparathyreózy
Sylvie Dusilová Sulková, Vladimír Palička .................................................. 38

Vitamin D – imunomodulační hormon
Jiřina Bartůňková ....................................................................................... 46

 Preimplantační genetické testování u pacientů s ADPKD
Pavel Navrátil, Pavel Navrátil, Jan Diblík,
Kateřina Sobolová, Veronika Sabolová,
Jitka Štekrová, Jiří Doležal ......................................................................... 52

Rozhovor

MUDr. Jana Lachmanová ........................................................................... 59

Předplatné ................................................................................................ 63

Pokyny autorům ....................................................................................... 64

 

CONTENTS

Editorial .................................................................................................... 33

Contents ................................................................................................... 35

Reviews

Vitamin D and VDR activators – new developments
in the prevention and treatment of secondary hyperparathyroidism
Sylvie Dusilová Sulková, Vladimír Palička ................................................... 38

Vitamin D – an immunomodulatory hormone
Jiřina Bartůňková ........................................................................................ 46

Preimplantation genetic testing in patients with ADPKD
Pavel Navrátil, Pavel Navrátil, Jan Diblík, Kateřina Sobolová,
Veronika Sabolová, 
Jitka Štekrová, Jiří Doležal ........................................... 52

Interview

MUDr. Jana Lachmanová ............................................................................ 59

Subscription ............................................................................................... 63

Instruction for authors ............................................................................... 64

OBSAH

Editorial .................................................................................................. 1

Obsah ..................................................................................................... 3

Doporučený postup

Doporučený postup pro využití perkutánní
endovaskulární arteriovenózní fistule (endoAVF)
jako cévního přístupu k chronické hemodialýze
v České republice ................................................................................. 7

Přehledné články

Dysurie
Pavel Navrátil, Minh Nguyet Tranová,
Sylvie Dusilová Sulková ...................................................................... 12

Kompletně nové pojetí CKD-MBD?
Sylvie Dusilová Sulková, Vladimír Palička .......................................... 17

Artériová hypertenzia, reštrikcia sodíka
a inzulínová rezistencia
Štefan Sotak ........................................................................................ 24

Rozhovor
Prof. MUDr. Jan Malík, CSc. ................................................................ 30

Pokyny autorům ................................................................................... 32

CONTENTS

Editorial ................................................................................................... 1

Contents .................................................................................................. 3

Recommended protocol

Recommended protocol for the use of a percutaneous
endovascular arteriovenous fistula (endoAVF)
as vascular access for chronic hemodialysis
in the Czech Republic ............................................................................ 7

Reviews

Dysuria
Pavel Navrátil, Minh Nguyet Tranová,
Sylvie Dusilová Sulková ....................................................................... 12

A completely new approach to CKD-MBD?
Sylvie Dusilová Sulková, Vladimír Palička ............................................ 17

Arterial hypertension, sodium restriction
and insulin resistance
Štefan Sotak .......................................................................................... 24

Interview
Prof. MUDr. Jan Malík, CSc. .................................................................. 30

Instruction for authors ............................................................................. 32